PRAME CLIA Kit

Produktnummer ABIN6205716

Produktdetails PRAME CLIA Kit

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Reaktivität: Human

Nachweismethode: Chemiluminescent

Methodentyp: Sandwich ELISA

Detektionsbereich: 0.312 ng/mL - 20 ng/mL

Untere Nachweisgrenze: 0.312 ng/mL

Applikation: ELISA

Verwendungszweck: Human Preferentially Expressed Antigen In Melanoma (PRAME) CLIA Kit is a Sandwich CLIA Kit for use with Tissue homogenates, cell lysates, cell culture supernates and other biological fluids.

Proben: Cell Culture Supernatant, Cell Lysate, Tissue Homogenate

Analytische Methode: Quantitative

Sensitivität: < 0.117 ng/mL

Anwendungsinformationen

Applikationshinweise:

Stability: The stability of the kit is determined by the rate of activity loss. The loss rate is less than 5 % within the expiration date under appropriate storage conditions. To minimize performance fluctuations, operation procedures and lab conditions should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same user throughout.

Recommended dilutions: Optimal dilutions/concentrations should be determined by the end user.

Standard Form: Lyophilized

Plattentyp: Pre-coated

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Upon receipt, store the kit according to the storage instruction in the kit's manual.

Haltbarkeit: 6 months

Antigendetails

Target: PRAME (Preferentially Expressed Antigen in Melanoma (PRAME))

Abstract: PRAME Produkte

Synonyme: PRAME CLIA Kit, CT130 CLIA Kit, MAPE CLIA Kit, OIP-4 CLIA Kit, OIP4 CLIA Kit, 4930534P07Rik CLIA Kit, preferentially expressed antigen in melanoma CLIA Kit, PRAME CLIA Kit, Prame CLIA Kit

Pathways: Retinoic Acid Receptor Signaling Pathway, Nuclear Hormone Receptor Binding